Original document(11 pages)  中文版
    Antitumor formulation based on nanoparticles of paclitaxel and human serum albumin as obtained by the addition of a biocompatible acid to an aqueous albumin solution before this is mixed with paclitaxel during the nanoparticle production process, the injectable solutions of this formulation having a pH between 5.4 and 5.8 and having stability and inalterability with time.
Application Number
申请号		 200610091256 Application Date
申请日		 2003.03.28
Title 名称 Improved paclitaxel-based antitumor formulation
Publication Number
公开号		 1935121 Publication Date
公开日		 2007.03.28
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/19;A61K31/337;A61K47/42;A61P35/00
Applicant(s) Name
申请人		 Acs Dobfar SPA
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 lihua yang
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.